ArticleCritical care (London, England)2020

Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease.

Lucas Liaudet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.